Medicure (MCUJF) Cash from Investing Activities Growth (1y) (2011 - 2026)
Medicure (MCUJF) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -308.05% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -41.51% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -139.86% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 129.18% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.71% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -366.90% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -96.43% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Medicure | 97.06 Mn | 95.93 Mn | 2.57 Mn | 26.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.25% |
| Dec 31, 2025 | 130.19% |
| Jun 30, 2025 | -1,451.84% |
| Mar 31, 2025 | -485.05% |
| Dec 31, 2024 | -241.10% |
| Sep 30, 2024 | 14.54% |
| Mar 31, 2024 | -223.28% |
| Sep 30, 2023 | 58.41% |
| Mar 31, 2023 | 46.18% |
| Sep 30, 2022 | -12.88% |
| Sep 30, 2017 | -3,861.11% |
| Jun 30, 2017 | -9,531.39% |
| Mar 31, 2017 | -2,514.88% |
| Dec 31, 2016 | -14,268.34% |
| Sep 30, 2016 | 62.22% |
| Jun 30, 2016 | -64.28% |
| Mar 31, 2016 | -46.82% |
| May 31, 2014 | -120.41% |
| May 31, 2013 | 145.66% |
| Feb 28, 2013 | 11.79% |